Japanese Journal of Ophthalmology

Papers
(The TQCC of Japanese Journal of Ophthalmology is 3. The table below lists those papers that are above that threshold based on CrossRef citation counts [max. 250 papers]. The publications cover those that have been published in the past four years, i.e., from 2021-12-01 to 2025-12-01.)
ArticleCitations
Two-year outcomes of anterior versus posterior scleral application of mitomycin C-soaked sponge in trabeculectomy60
Short-term efficacy and safety of PreserFlo MicroShunt in Japanese patients with medically treated primary open-angle glaucoma29
2021 trends in the treatment of patients with strabismus in Japan29
Two-year treatment outcomes after anti-vascular endothelial growth factor therapy in age-related macular degeneration with type 2 macular neovascularization in Japanese patients28
Effects of trabeculectomy on the postoperative central visual field as revealed by refraction values24
The optimal cut-off value of non-cycloplegic autorefraction for diagnosing myopia in school-aged children24
Involvement of best-corrected visual acuity in sarcopenia: findings from baseline analysis of the Kyotango longevity cohort study23
Hypertensive phase after a novel small-lumen non-valved drainage device: predictive factors and two-year outcomes23
Choroidal circulation time by wide-field indocyanine green angiography in central serous chorioretinopathy22
Intravenous immunoglobulin for the acute treatment of refractory optic neuritis in Japan22
Displacement of the retina and changes in the foveal avascular zone area after internal limiting membrane peeling for epiretinal membrane21
Temporal changes in parameters associated with tear film stability after instillation of long-acting diquafosol ophthalmic solution in soft contact lens wearers20
Intraocular pressure at different gaze positions in patients with highly myopic strabismus17
Usage status of biologics for the chronic treatment of optic neuritis in neuromyelitis optica spectrum disorders in Japan17
Analysis of treatment protocols using azithromycin eye drops for bacterial blepharitis: second report—bacteriological investigation15
Comparison of intraocular pressure elevation following intravitreal injection of 70 µl aflibercept 8 mg15
Two-year clinical outcomes of triple therapy with photodynamic therapy, anti-vascular endothelial growth factor agent, and triamcinolone acetonide for neovascular age-related macular degeneration15
Three-year efficacy and safety of omidenepag isopropyl in patients with normal tension glaucoma14
RNA-seq analysis of human trabecular endothelial cells after treatment with timolol maleate14
Congenital nasolacrimal duct obstruction: clinical guideline14
Clinical features and prognosis of conjunctival melanoma in Japanese patients14
Efficacy of a 0.05% cyclosporine a topical nanoemulsion in dry eyes with obstructive meibomian gland dysfunction14
Lens factor as an underlying mechanism in primary angle closure with gonioscopically-visualized ciliary body processes13
Japanese clinical guidelines for neovascular age-related macular degeneration12
Correction to: Investigation of satisfaction with short‑term outcomes after switching to faricimab to treat neovascular age‑related macular degeneration12
Association between the arm-to-choroidal circulation time and clinical profile in patients with polypoidal choroidal vasculopathy11
Vitreoretinal interface anomalies in patients with a history of toxoplasmosis retinochoroiditis11
Posterior vitreous detachment after cataract surgery in eyes with high myopia: an optical coherence tomography study11
Impairment of flicker-induced increase in retinal blood flow in diabetic pigs11
Ocular genetics in the Japanese population11
Subtype prevalence and baseline visual acuity by age in Japanese patients with neovascular age-related macular degeneration11
Efficacy of 3% diquafosol long-acting eye drops in dry eye patients treated for three months10
Efficacy, durability, and safety of faricimab with extended dosing up to every 16 weeks in diabetic macular edema: 2-year results from the Japan subgroup of the phase 3 YOSEMITE trial10
Choroidal imaging using optical coherence tomography: techniques and interpretations9
Galectin-3, a damage-associated molecular pattern, in tears of patients with vernal keratoconjunctivitis9
Association between the retinal age gap and systemic diseases in the Japanese population: the Nagahama study9
Multicenter prospective observational study of fungal keratitis in Japan: analyses of culture-positive cases9
Recent trends in anti-vascular endothelial growth factor intravitreal injections: a large claims database study in Japan9
Ab interno removal of malpositioned ex-press glaucoma device combined with bleb needling8
Central serous chorioretinopathy and the sclera: what we have learned so far8
Implementation of pneumatic retinopexy in the Japanese population8
Prevalence of dry eye syndrome and risk factors in physical education and sports science graduates8
Comparative study of efficacy and safety of pulse versus half-pulse steroid therapy for Vogt-Koyanagi-Harada Disease8
Six-month comparative outcomes of aflibercept and faricimab in treatment-naïve macular edema secondary to branch retinal vein occlusion8
Comparative study of surgical outcomes regarding tear meniscus area and high-order aberrations between two different interventional methods for primary acquired nasolacrimal duct obstruction8
Correction to: Efficacy, durability, and safety of faricimab up to every 16 weeks in patients with neovascular age-related macular degeneration: 1-year results from the Japan subgroup of the phase 3 T7
Measuring macular pigment optical density using reflective images of confocal scanning laser system7
Injectable in situ cross-linking hyaluronan hydrogel for easier removal of posterior vitreous cortex in vitrectomy7
Orientation of the intermediate-vision zone of rotationally asymmetric multifocal intraocular lenses and photic phenomena7
Efficacy of scleral imbrication on all quadrants in enucleated pig eyes7
Incidence and risk factors of late-onset intraocular pressure elevation after vitrectomy with silicone oil tamponade7
Risk factors for intraocular pressure elevation during the early period post cataract surgery6
Surgical outcomes after trabeculotomy for primary congenital glaucoma6
Efficacy and limitations of amniotic membrane transplantation in cases of severe ocular surface disorders: retrospective analysis over a 21-year period6
Epidemiological characteristics of malignant eyelid tumors at a referral hospital in Japan6
Effects of ethylenediaminetetraacetic acid chelation for calcific band keratopathy on corneal topography assessed by fourier harmonic analysis6
Comparison of iodine compounds and levofloxacin as postoperative instillation; conjunctival bacterial flora and antimicrobial susceptibility following cataract surgery6
Choroidal changes after vitrectomy performed for macular hole retinal detachment6
Retinal displacement and intraretinal structural changes after idiopathic macular hole surgery6
Visual function and patient satisfaction with 3 types of monofocal plus intraocular lenses6
Safety and efficacy of ripasudil eye drops in preterm infants with retinopathy of prematurity: phase 1/2, open label, single-arm trial6
Clarity of surgical field displayed on 3D monitor with local dimming technology during heads-up surgery6
Differential diagnosis and clinical predictors in suspected optic neuritis6
Periocular methotrexate versus periocular triamcinolone injections for active thyroid-associated orbitopathy: a randomized clinical trial5
Visual cortex damage in a ferret model of ocular hypertension5
Exophthalmos associated with chronic progressive external ophthalmoplegia5
Recurrence associated with 2-year visual acuity after subretinal tissue plasminogen activator for submacular hemorrhage in neovascular age-related macular degeneration5
Changes in cataract and refractive surgery practice patterns among JSCRS members over the past 20 years5
Study protocol for a prospective natural history registry investigating the relationships between inflammatory markers and disease progression in retinitis pigmentosa: the RP-PRIMARY study5
Long-term outcomes and prognosis in vitrectomy with autologous platelet concentrate injection for large, high myopic, or recurrent macular holes5
Reconsideration of conversion to multiple sclerosis: one-year cerebral lesion appearance rate of Japanese aquaporin-4 antibody-negative optic neuritis patients5
Efficacy and safety of the paul glaucoma implant in the treatment of refractory primary congenital glaucoma5
Clinical presentations of acquired comitant esotropia in 5–35 years old Japanese and digital device usage: a multicenter registry data analysis study5
Diagnosis and management of vitreoretinal lymphoma: present and future treatment perspectives5
Mutations of CYP1B1 and FOXC1 genes for childhood glaucoma in Japanese individuals5
Corneal refractive error and astigmatism in patients aged 6 to 18 years with a history of retinopathy of prematurity and birth weight of <1500 g5
The 2023 revised diagnostic criteria for IgG4-related ophthalmic disease4
Profiling miRNAs in tear extracellular vesicles: a pilot study with implications for diagnosis of ocular diseases4
Characteristics of dry eye associated with autoimmune diseases4
Clinical presentation and prognostic factors of eyelid sebaceous carcinoma4
Open globe injuries: clinical features and risk factors at a tertiary hospital in Vietnam4
A single center experience of intraocular pressure control with glaucoma drainage device use in pediatric and adult patients4
Investigation of satisfaction with short-term outcomes after switching to faricimab to treat neovascular age-related macular degeneration4
Medial rectus insertion site in cases of acute acquired comitant esotropia associated with excessive digital device usage4
Retinal displacement using optical coherence tomography angiography and metamorphopsia in eyes undergoing macular hole surgery4
Structure-function relationship between magnetic resonance imaging lesion areas and visual field defects in initial optic neuritis with altitudinal hemianopsia4
Association between central serous chorioretinopathy susceptibility genes and choroidal parameters4
Efficacy of switching to brolucizumab for neovascular age-related macular degeneration refractory to faricimab4
National survey of amblyopia treatment in Japan: comparison with amblyopia treatment study results of the pediatric eye disease investigator group4
Steroid-induced ocular hypertensive response in pediatric patients with acute lymphoblastic leukemia3
Correlation between extraocular muscle enlargement and thyroid autoantibodies in thyroid eye disease3
Relationships between tilt angles of rectus muscles and positions of rectus muscle pulleys in patients with sagging eye syndrome3
Factors predicting the treatment frequency of ranibizumab injections during the second year in diabetic macular edema3
Evaluation of contamination in preservative-free multi-dose Brimonidine eye drops: a comparative study3
Midterm outcomes of Ahmed glaucoma valve implantation and trabeculectomy in exfoliative glaucoma3
Exophthalmos associated with chronic progressive external ophthalmoplegia3
Treatment outcomes of patients with neovascular age-related macular degeneration after switching from aflibercept to faricimab3
Efficacy, durability, and safety of faricimab up to every 16 weeks in patients with neovascular age-related macular degeneration: 1-year results from the Japan subgroup of the phase 3 TENAYA trial3
Impact of prolonged digital device use on acquired comitant esotropia: ACE-DD study 23
Refractive error and axial length prediction using fundus parameters of normal eyes in the Kumejima population study3
Role of perfusion-related metrics in visual field progression of primary open-angle and exfoliation glaucoma: a natural language processing approach3
Efficacy of a wearable night-vision aid in patients with concentric peripheral visual field loss: a randomized, crossover trial3
Intraocular pressure-lowering effects and safety of brimonidine/brinzolamide fixed combination after switching from other medications3
Correction to: Analysis of treatment protocols using azithromycin eye drops for bacterial blepharitis: second report—bacteriological investigation3
Correction to: Additive effects of brimonidine tartrate 0.1%/brinzolamide 1% fixed‑dose combination in prostaglandin analog‑treated Japanese glaucoma patients3
Assessment of punctal metrics and tear meniscus height in epiphora: clinical insights and diagnostic potential3
Association between treatment for retinopathy of prematurity and blood monocyte counts3
The Japan Glaucoma Society guidelines for glaucoma 5th edition3
Validation of the postnatal growth and retinopathy of prematurity (G-ROP) screening criteria in a Thai cohort3
Rescue pneumatic retinopexy for recurrent retinal detachments due to superior retinal breaks following initial vitrectomy3
Assessment of objective visual function following idebenone administration in patients with leber hereditary optic neuropathy3
Correction to: Effectiveness of a photoscreener in identifying undiagnosed unilateral amblyopia at vision screening of 3-year-old children in Japan3
Intraocular pressure changes during intravitreal aflibercept injection based on treat-and-extend regimen in Japanese patients with neovascular age-related macular degeneration and glaucoma3
Evaluation of 60 months long-term results of accelerated corneal cross-linking treatment in pediatric keratoconus patients with new progression indices3
Correlation between internal limiting membrane preservation and sub-epiretinal membrane space during epiretinal membrane surgery3
0.53524994850159